AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vilbuzz Met 1000mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Nirvana India Pvt Ltd

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Vilbuzz Met 1000mg/50mg Tablet

Metformin/Pioglitazone 1000mg/50mg tablets effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication mitigates the risk of severe diabetic complications, including renal impairment and vision loss, and may lessen the probability of cardiovascular events. This treatment may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved when combined with a balanced diet and regular physical activity. Dosage is personalized, reflecting individual health status, glycemic control, and concurrent medications. Ingestion with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Maintaining controlled blood sugar levels prevents future complications. Adherence to the prescribed diet and exercise plan is crucial for successful diabetes management; lifestyle choices significantly impact glycemic control. Common adverse effects include diarrhea, nausea, vomiting, dyspepsia, cephalgia, pharyngitis, asthenia, GERD, diaphoresis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, requires appropriate recognition and management. This medication is not universally suitable. Prior to initiating therapy, patients with renal, hepatic, or cardiac disease, pancreatic dysfunction, or significant alcohol consumption should inform their physician. Pregnant or lactating women require medical consultation before use. Potential drug interactions necessitate comprehensive disclosure of all medications to ensure patient safety. Alcohol should be limited due to its hypoglycemic effects. Renal function and blood glucose levels will be monitored by your doctor throughout treatment.

Uses of Vilbuzz Met 1000mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vilbuzz Met 1000mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Vilbuzz Met 1000mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Vilbuzz Met 1000mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vilbuzz Met 1000mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Vilbuzz Met 1000mg/50mg tablets should be administered with a meal.

How Vilbuzz Met 1000mg/50mg Tablet works:

Each Vilbuzz Met 1000mg/50mg tablet contains a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Vilbuzz Met 1000mg/50mg Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vilbuzz Met 1000mg/50mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks before prescribing. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and the use of Vilbuzz Met 1000mg/50mg tablets are likely incompatible. Available human data indicates potential drug transfer via breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose levels are abnormally low or elevated. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vilbuzz Met 1000mg/50mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Use of Vilbuzz Met 1000mg/50mg Tablet is likely inadvisable for individuals with hepatic impairment and should be avoided. Seek medical advice before use.

What if you forget to take Vilbuzz Met 1000mg/50mg Tablet :

Should you forget to take a Vilbuzz Met 1000mg/50mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Vilbuzz Met 1000mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vilbuzz Met 1000mg/50mg Tablet

Vilbuzz Met 1000mg/50mg tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Nausea and vomiting are possible side effects of Vilbuzz Met 1000mg/50mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always consult your doctor before taking any other medication.
Vilbuzz Met 1000mg/50mg Tablet is contraindicated in patients allergic to its components or excipients. It should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vilbuzz Met 1000mg/50mg tablets combine metformin (a biguanide) and vildagliptin, both used to treat diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vilbuzz Met 1000mg/50mg Tablets can cause lactic acidosis, a serious medical emergency involving excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue use and seek immediate medical attention.
Prolonged use of Vilbuzz Met 1000mg/50mg Tablet can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Vilbuzz Met 1000mg/50mg Tablet as directed by your doctor is safe. However, even with correct dosage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (if also taking insulin or sulphonylurea). Report any persistent side effects to your doctor.
Vilbuzz Met 1000mg/50mg T...
136
MRP 158
13% off